IP Library › Granted Patent US 11,137,394
Granted Patent B2
US 11,137,394 · App. 15/551,164 · Granted Oct 5, 2021

Systems and methods for performing immunoassays

Inventors: Pengyu Chen (Ann Arbor, MI); Katsuo Kurabayashi (Ann Arbor, MI); Timothy T. Cornell (Ann Arbor, MI); Thomas P. Shanley (Ann Arbor, MI); Meng Ting Chung (Ann Arbor, MI); Yujing Song (Ann Arbor, MI); Walker M. McHugh (Dexter, MI)
Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
G01N33/54373B01L3/5027C40B40/10G01N33/54346B01L2300/0636B01L2300/0645B01L2300/0816B01L2300/0861B01L2300/0877B01L2300/123B01L2300/161B01L2400/043B01L2400/0406B01L2400/0415B01L2400/0442B01L2400/0457B01L2400/0487
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,137,394
App. No.
15/551,164
Filed
Aug 15, 2017
Granted
Oct 5, 2021
Kind
B2
Art Unit
1641
USPC
436/525
Abstract

Provided herein are systems and methods for assays. In particular, provided herein are systems and methods for performing high throughput immunoassays. Embodiments of the present disclosure provide multiplex capable LSPR immunoassays that meet a need for rapid (e.g., near real time), accurate immunoassays (e.g. for use in beside diagnostics). The LSPR assays are as accurate as existing ELISA assays but provide the advantage of increased speed and multiplex capability. In addition, the LSPR immunoassays are able to analyze small volumes of complex patient samples (e.g., serum).

Claims (19)

1. A localized surface plasmon resonance (LSPR) device, comprising:

a first substrate having a first broad surface;

an array of metals particles coupled to the first broad surface of the first substrate, wherein the array of metal particles comprises nanoparticles patterned along a first direction relative to the first substrate, and wherein the array of metal particles is functionalized with antibodies specific for at least one polypeptide;

a second substrate coupled to the first broad surface of the first substrate and defining a plurality of microfluidic channels in fluid communication with the array of metal particles, wherein the plurality of microfluidic channels has an inlet and an outlet and is oriented orthogonal to the first direction, wherein each of the plurality of microfluidic channels has a volume of 10 μl to 10 μL, and wherein a microfluidic channel of the plurality of microfluidic channels comprises a first channel dimension at one of the inlet and the outlet that is smaller than a second channel dimension at an intermediate portion of the microfluidic channel, thereby transmitting the sample, in the assessment mode, by capillary force;

wherein the device is operable in an assessment mode wherein:

the plurality of microfluidic channels contains a sample, comprising a target polypeptide component associated with inflammatory response, from a subject,

an interaction between the target polypeptide component and the antibodies functionalized at the array of metal particles produces a set of signals associated with light scattering, and

the set of signals is detected at an optical detection platform through at least one of the first substrate and the second substrate.

2. The device of claim 1 , wherein said antibodies comprise a plurality of antibodies, wherein each antibody is specific for a different polypeptide.

3. The device of claim 2 , wherein the plurality of polypeptides comprises at least one of: cytokines, proteins, antibodies, and nucleic acids.

4. The device of claim 3 , wherein the plurality of polypeptides comprise cytokines comprising at least two of interleukin-2 (IL-2); interleukin-4 (IL-4); interleukin-6 (IL-6); interleukin-8 (IL-8); interleukin-10 (IL-10); interleukin-12 (IL-12); interferon-gamma (IFN-y); and tumornecrosis-factor alpha (TNF-a).

5. The device of claim 1 , wherein said substrate comprises at least 100 antibodies coupled to the array of metal particles, and wherein the first substrate is treated with at least one of oxygen plasma, UV/ozone, and silanization.

6. The device of claim 1 , wherein the first substrate is composed of at least one of glass and thermoplastic.

7. The device of claim 1 , wherein the array of metal particles comprises particles composed of at least one of gold, silver, copper, titanium, and chromium fabricated into at least one of: nanorods, nanostars, nanopyramids, nanodiamonds, nanorings, and core-shells.

8. The device of claim 7 , wherein said antibodies are attached to surface via a linker, and wherein the linker comprises a is C1-C10 bifunctional thiollinker.

9. The device of claim 1 , wherein the first substrate further comprises a plurality of microelectrodes configured for electroosmosis and in operable communication with the array of metal particles.

10. The device of claim 9 , wherein metal nanoparticles of the array of metal nanoparticles are in operable communication with pairs of the plurality of microelectrodes, and wherein each of the plurality of microelectrodes is configured to deliver alternating current.

11. The device of claim 1 , further comprising:

a LSPR detection apparatus comprising the optical detection platform, wherein the optical detection platform includes a lens coupled to a motorized stage supporting the first substrate, the lens operable to transmit light from the interaction through a signal filter and to a sensor subsystem in communication with a computing subsystem for processing of the set of signals.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: CHEN, PENGYU; KURABAYASHI, KATSUO; CORNELL, TIMOTHY T.; SHANLEY, THOMAS P.; CHUNG, MENG TING; SONG, YUJING; MCHUGH, WALKER M.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 043778/0747 →
Continuity (3)
Provisional Application 62245066 · Oct 22, 2015
Provisional Application 62116741 · Feb 16, 2015
Related Publication 20180031549A1 · Feb 1, 2018
Cited By (1)
US 12,385,818